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Abstract
Background: In the context of drug discovery, drug target interactions (DTIs) can be predicted based on observed
topological features of a semantic network across the chemical and biological space. In a semantic network, the
types of the nodes and links are different. In order to take into account the heterogeneity of the semantic network,
meta-path-based topological patterns were investigated for link prediction.
Results: Supervised machine learning models were constructed based on meta-path topological features of an
enriched semantic network, which was derived from Chem2Bio2RDF, and was expanded by adding compound and
protein similarity neighboring links obtained from the PubChem databases. The additional semantic links significantly
improved the predictive performance of the supervised learning models. The binary classification model built upon the
enriched feature space using the Random Forest algorithm significantly outperformed an existing semantic link
prediction algorithm, Semantic Link Association Prediction (SLAP), to predict unknown links between compounds and
protein targets in an evolving network. In addition to link prediction, Random Forest also has an intrinsic feature
ranking algorithm, which can be used to select the important topological features that contribute to link prediction.
Conclusions: The proposed framework has been demonstrated as a powerful alternative to SLAP in order to predict
DTIs using the semantic network that integrates chemical, pharmacological, genomic, biological, functional, and
biomedical information into a unified framework. It offers the flexibility to enrich the feature space by using different
normalization processes on the topological features, and it can perform model construction and feature selection at
the same time.
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Background
Chemogenomics [1, 2] and chemical systems biology [3, 4]
aim to accelerate drug discovery inexpensively through in
silico predictions, based on a network with enriched drug-
target-disease relationships [5]. Integrated chemical and
biological networks can be used to hypothesize new clin-
ical indications for approved drugs with desired safety
profiles, and to propose new combination therapy design
[6, 7]. Drug-target interaction networks can also be uti-
lized to interpret clinical side effects by revealing modes of
drug actions [8]. Semantic standards and technologies fa-
cilitate seamless data integration across multiple domains,
and enable the construction of a heterogeneous network
consisting of various biological entities of different types,
such as compounds, proteins, and genes [9]. Several se-
mantically linked datasets, such as PubChemRDF [10],
Chem2Bio2Rdf [11], Bio2RDF [12], Open PHACTS [13],
and ChEMBL RDF [14], have been published to promote
large-scale data mining in drug discovery. A statistical
model, called Semantic Link Association Prediction
(SLAP), has been applied to Chem2Bio2RDF to predict dir-
ect links between compounds and proteins based on their
indirect links or paths with other biological objects, such
as substructures, diseases, side effects, and pathways [15].
It has been demonstrated that SLAPas a novel and vali-
dated approach to predict drug-target interactions (DTIs)
outperformed existing alternatives.
Predicting DTI is equivalent to link prediction, which
is a fundamental problem and long-standing challenge
in complex network analysis [16]. In social networks,
topological proximity, measured based on observed net-
work data, can be used to suggest future interactions
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between individuals [17]. In the context of drug discov-
ery, biological networks can be similarly leveraged to
identify potential associations between compounds and
protein targets. Typical network-based DTI predictions
are often based on similarity profiles calculated from
common neighbors or direct connections, and are usually
limited to bipartite networks [18–21]. However, most
similarity-based link prediction algorithms designed for
homogeneous networks cannot take into account the het-
erogeneous types and relations defined in semantic net-
works; furthermore, it is fairly challenging to consider the
long paths connecting two end nodes (indirect connec-
tions), which can significantly increase large volumes of
randomness in the connectivity. Therefore, we incorpo-
rated meta-path topological features [22] for link predic-
tion. A meta-path is a composite relation, denoting a
sequence of adjacent links between any two objects in a
heterogeneous network. Adjacent links are defined with
distinct semantics, so different combinations of adjacent
links in sequences contribute distinguishably for link pre-
diction. It has been proven that meta-path-based similarity
can improve the performance of information retrieval in
heterogeneous information networks [23].
A meta-path defines a certain type of paths linking the
starting and ending objects. The total number of paths
belonging to a specific meta-path is animportant topo-
logical feature to evaluate the strength of associations
between starting and ending objects, which is often
called path count. For instance, a compound and a pro-
tein target can be connected through multiple paths
of different types: (A) compound→similar to compound
→
binds to protein; (B) compound→binds to protein→binds to
compound→binds to protein; and (C) compound→has part
substructure→part of compound→binds to protein→similar to
protein. Three meta-paths connect the starting com-
pound to the ending protein: meta-path (A) indicates
that the compound most likely binds to a protein to
which another structurally similar compound binds;
meta-path (B) shows that two compounds sharing an
observed protein target may share another protein
target as well; meta-path (C) specifies that two com-
pounds sharing a common substructure may bind to
two different protein targets that have similar protein
sequences. SLAP employs a statistical model to evalu-
ate the importance of each meta-path in link predic-
tion, which is evaluated individually based on the
distribution of its connectivity property over a set of
randomly sampled drug-target pairs. Several meta-
paths are selected according to their statistical signifi-
cances, and the aggregated connectivity properties of
the selected meta-paths are used to predict DTI.
The present work provides an alternative DTI approach
to SLAP. Rather than using a statistical model to study
the significance of meta-path topological features, we
propose a framework to take advantage of machine learn-
ing algorithms, including Random Forest (RF) and
Support Vector Machine (SVM), to construct binary
classification models to predict DTI. A more complete
drug-target connectivity map can be constructed using
the predicted links. By using machine learning models,
feature importance (i.e., the contributions of different
meta-paths to the link prediction) can be calculated at the
same time as the classification models are built. Addition-
ally, SLAP only considers path counts as a topological
feature; whereas our approach can apply different kinds of
normalization processes to path counts, including random
walk, normalized path count, and symmetric random walk
[23] to further enrich the topological feature space. In
order to compare our approach with SLAP, we have
carried out link prediction experiments on a semantic
network, called Chem2Bio2Rdf, which focuses on drug
candidates and their biological annotations. Although the
proposed approach was just used to construct a more
complete drug-target connectivity map in the present
study, it can be generalized as a framework to leverage
machine learning algorithms to study the topological
features of the heterogeneous network for link prediction.
Structural similarity links between compounds and se-
quence similarity links between proteins were added to
expand the semantic network. The usefulness of similarity
neighboring links from PubChem resources [24] is exam-
ined in the context of semantic link prediction.
Methods
Semantic network
In the Chem2Bio2RDF semantic network, nine distinct
semantic types are presented, including compounds,
proteins, adverse side effects, Gene Ontology (GO) an-
notations, ChEBI types, substructures, tissues, biological
pathways, and diseases; ten different semantic links are
incorporated, including links from compounds to ChEBI
types, from compounds to proteins, from compounds to
substructures, from adverse side effects to compounds,
from diseases to compounds, from proteins to proteins
(referring to protein-protein interactions), from proteins
to GO annotations, from diseases to proteins, from path-
ways to proteins, and from tissues to proteins. In order to
enhance link prediction performance, we enriched the
linked dataset by adding two more semantic links: com-
pound neighboring links based on 2D structural similarity,
and protein neighboring links, based on sequence similar-
ity. The similarity neighboring links were obtained from
PubChem databases [25, 26]. A total of twelve adjacency
matrixes were computed based on the semantic links be-
tween any two objects. The elements of the adjacency ma-
trixes have two values: ‘0,’ indicating unobserved links, and
‘1,’ indicating observed links. The semantics and statistics
of adjacency matrixes were enumerated in Table 1; these
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were used to calculate the meta-path-based topological
features. It is noteworthy that all the semantic links in the
Chem2Bio2RDF dataset are reversible, and the adjacency
matrix for the reverse semantic links can be obtained
through a transpose of the original adjacency matrix.
Meta-path-based topological features
The meta-path topological features were encoded in
commuting matrixes, calculated by multiplying several
adjacency matrixes. To predict the links from com-
pounds to proteins, we exhaustively enumerate all the
possible meta-paths, yielding a total of 51 meta-paths.
Each commuting matrix represents a certain type of
meta-path of a given length. The length of the meta-
paths equals the number of multiplied adjacency ma-
trixes. Out of 51 commuting matrixes, 4 meta-paths are
of length 2; 11 meta-paths are of length 3; and 36 meta-
paths are of length 4. The meta-paths with length
greater than 4 are considered to be too long to make a
significant contribution to link prediction. The elements
in the commuting matrix indicate the number of path
instances linking compounds to proteins, and have non-
negative integer values. The semantics and statistics of
commuting matrixes were enumerated in Table 2. For
instance, the commuting matrix C15 represents a meta-
path: compound→similar to compound→binds to protein
→
similar to protein, which was calculated by multiplying
three adjacency matrixes: A2, A11, and A12 (Fig. 1). All
of the matrix multiplications were carried out using the
Armadillo C++ linear algebra library [27], and all of the
adjacency and commuting matrixes were encoded as
sparse matrixes to reduce memory consumption.
Two measures of topological features were calculated.
Path count (PCi,j) measures the number of path instances
between nodes i and j, which corresponds to the value of
element in the commuting matrix. We also applied
Random Walk (RW) as a normalization process to the
number of path instances, based on the overall connectivity
of the network. RW was calculated as PCi;j

PCi;• , where
PCi,• are row-wise summations.
Machine learning dataset
In order to build supervised learning models, both po-
sitive and negative labels are required. We treated
observed links between compounds and protein targets
as positive labels. A total of 5,387 positively labeled links
from Drugbank were collected, which were used to
evaluate the predictive performance of the SLAP algo-
rithm [15]. The unobserved links in the dataset can be
either spurious links or potential future links. In order
to obtain experimental evidence for the negative labels,
we surveyed the PubChem BioAssay database [28]: if the
experimental bioactivity value is greater than 10 μM, the
link of a compound protein pair is negatively labeled.
Accordingly, we obtained 26,682 negative labels out of
over 5.6 billion unobserved links between compounds
and proteins in the Chem2Bio2RDF semantic network.
In order to assess predictive performance without prior
knowledge, the positively labeled links were removed
from Chem2Bio2RDF when the meta-path-based topo-
logical features were calculated. The positively and
negatively labeled links were combined and randomly
split into training and test sets by a ratio of 2:1. In
the training set, there are 3,591 positively labeled
links and 17,788 negatively labeled links. In the test
set, there are 1,796 positively labeled links and 8,894
negatively labeled links.
The network evolves as new links are identified over
time. In order to further examine the ability of the pro-
posed framework to identify the evolution of network
Table 1 The semantics and statistics of adjacency matrixes
Index Semantics From Number of Rows To Number of Colums Counta
A1 has ChEBI type compound 258030 ChEBI type 2777 14633
A2 binds to compound 258030 protein 22056 528831
A3 has part compound 258030 substructure 290 6127
A4 induced by adverse side effect 1051 compound 258030 9004
A5 treated by disease 1284 compound 258030 927
A6 interacts with protein 22056 protein 22056 72773
A7 has GO annotation protein 22056 GO annotation 9710 89688
A8 caused by disease 1284 protein 22056 2676
A9 has participants pathway 192 protein 22056 10796
A10 expresses tissue 507 protein 22056 9905
A11 similar to compound 258030 compound 258030 6184722
A12 similar to protein 22056 protein 22056 261158
aThe number of non-zero elements in adjacency matrix
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Table 2 The semantics and statistics of commuting matrixes
Index Semantics Counta Maxb
C1 compound→similar to compound→binds to protein 1995778 395
C2 compound→binds to protein→interacts with protein 4878633 20
C3 compound→binds to protein→similar to protein 30665527 84
C4 compound→treats disease→caused by protein 6178 3
C5 compound→similar to compound→binds to protein→interacts with protein 15086309 934
C6 compound→similar to compound→binds to protein→similar to protein 49226573 1163
C7 compound→binds to protein→binds to compound→binds to protein 126339670 30400
C8 compound→has part substructure→part of compound→binds to protein 922056 202
C9 compound→has type ChEBI type→type of compound→binds to protein 709802 324
C10 compound→induces adverse side effect→induced by compound→binds to protein 420616 194
C11 compound→treats disease→treated by compound→binds to protein 68479 25
C12 compound→binds to protein→has annotation GO annotation→annotation of protein 316095950 335
C13 compound→binds to protein→participates in pathway→has participants protein 82834409 328
C14 compound→binds to protein→expressed in tissue→expresses protein 53586080 76
C15 compound→binds to protein→causes disease→caused by protein 1360337 10
C16 compound→binds to protein→binds to compound→binds to protein→interact with protein 522513250 142290
C17 compound→binds to protein→binds to compound→treats disease→caused by protein 12963831 498
C18 compound→binds to protein→binds to compound→similar to compound→binds to protein 201052081 777576
C19 compound→binds to protein→binds to compound→binds to protein→similar to protein 356122463 445332
C20 compound→type of ChEBI type→type of compound→binds to protein→interacts with protein 2333739 2711
C21 compound→type of ChEBI type→type of compound→treats disease→caused by protein 190923 194
C22 compound→type of ChEBI type→type of compound→binds to protein→similar to protein 1463743 8639
C23 compound→type of ChEBI type→type of compound→similar to compound→binds to protein 922257 8402
C24 compound→treats disease→treated by compound→binds to protein→interacts with protein 371971 162
C25 compound→treats disease→treated by compound→treats disease→caused by protein 38708 91
C26 compound→treats disease→treated by compound→binds to protein→similar to protein 493976 400
C27 compound→treats disease→treated by compound→similar to compound→binds to protein 106013 710
C28 compound→induces adverse side effect→induced by compound→binds to protein→interacts with protein 1766464 1622
C29 compound→induces adverse side effect→induced by compound→treats disease→caused by protein 168841 106
C30 compound→induces adverse side effect→induced by compound→binds to protein→similar to protein 1193429 5571
C31 compound→induces adverse side effect→induced by compound→similar to compound→binds to protein 765725 2744
C32 compound→has part substructure→part of compound→binds to protein→interacts with protein 3465967 902
C33 compound→has part substructure→part of compound→treats disease→caused by protein 355993 96
C34 compound→has part substructure→part of compound→binds to protein→similar to protein 2175094 2753
C35 compound→has part substructure→part of compound→similar to compound→binds to protein 1206786 12048
C36 compound→binds to protein→interacts with protein→has annotation GO annotation→annotation of protein 1064451402 1929
C37 compound→treats disease→caused by protein has annotation GO annotation→annotation of protein 2280505 136
C38 compound→binds to protein→similar to protein→has annotation GO annotation→annotation of protein 1480055439 50667
C39 compound→similar to compound→binds to protein has annotation GO annotation→annotation of protein 582316693 7765
C40 compound→binds to protein→interacts with protein→participates in pathway→has participants protein 246398750 2989
C41 compound→treats disease→caused by protein→participates in pathway→has participants protein 486267 183
C42 compound→binds to protein→similar to protein→participates in pathway→has participants protein 358346529 73327
C43 compound→similar to compound→binds to protein participates in pathway→has participants protein 149299008 7543
C44 compound→binds to protein→interacts with protein→causes disease→caused by protein 7603639 44
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connectivity, a much larger set of DTIs were collected
from the PubChem BioAssay database. PubChem Bio-
Assay categorizes depositor-provided bioactivities be-
tween compounds and protein targets into active,
inactive, and unspecified groups, according to assay
descriptions and activity values. If the interactions be-
tween compounds and protein targets are categorized as
active in PubChem BioAssay, and the active interaction
pairs have reported activity values of less than 1 μM, the
links are positively labeled; if the interactions between
compounds and proteins are categorized as inactive in
PubChem BioAssay, and there are reported activities for
the interactions, the links are negatively labeled. A set of
145,622 positively labeled links contained in the current
Chem2Bio2RDF semantic network, plus 600,000 nega-
tively labeled links, constitute a training set; another set
of 43,159 positively labeled links that are not contained
in the current Chem2Bio2RDF semantic network, but
are true positive DTIs, identified through bioassay exper-
iments, plus195,000 negatively labeled links, comprise
the test set. Since the positive DTIs in the test set were
obtained after construction of the network, this inde-
pendent test set is used to examine the ability to predict
the links in the future network based on the topological
features of the current network.
Binary classification models
In order to demonstrate how well the similarity neighbor-
ing links obtained from PubChem databases can improve
link prediction performance, we have constructed differ-
ent machine learning models, based on two sets of path
count topological features. Feature set I does not include
any meta-paths involving similarity neighboring links, so
it only contains 29 path count topological features.
Feature set II includes all of the path counts encoded in
51 commuting matrixes. We also examined the improve-
ment of predictive performance using an enriched topo-
logical feature space. RW normalization was applied to 51
path count topological features, and by combining the
path counts and random walks, we obtained feature set
III, which contains 102 topological features.
Two popular machine learning algorithms were investi-
gated. Random forest (RF) represents a collection of deci-
sion trees, which are grown from bootstrap samples of the
training data without pruning, and make predictions
based on majority votes of the ensemble trees [29]. RF
takes advantage of Out-of-Bag (OOB) error as an un-
biased estimate of generalized test error, so there is no
need to run cross-validation. RF can calculate the import-
ance of features as well. The values for a given feature are
permuted across all of the compound-protein pairs. Either
Table 2 The semantics and statistics of commuting matrixes (Continued)
C45 compound→treats disease→caused by protein→causes disease→caused by protein 27193 63
C46 compound→binds to protein→similar to protein→causes disease→caused by protein 26747896 802
C47 compound→similar to compound→binds to protein→causes disease→caused by protein 4159753 313
C48 compound→binds to protein→interacts with protein→expressed in tissue→expresses protein 222288200 453
C49 compound→treats disease→caused by protein→expressed in tissue→expresses protein 300620 27
C50 compound→binds to protein→similar to protein→expressed in tissue→expresses protein 431134094 5974
C51 compound→similar to compound→binds to protein→expressed in tissue→expresses protein 117576353 2031
a The number of non-zero elements in commuting matrix; b the max value of element in commuting matrix.
Fig. 1 Schematic representation of calculations of commuting matrix C15 through multiplying A2, A11, and A12
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classification accuracies or node impurities (Gini indexes)
are measured before and after permutations, and the
difference in the measures is used to evaluate feature im-
portance. A default value for the number of trees was used
(ntree = 500) in the present study, which has been proven
to be satisfactory in most cases [30]. The optimal value for
tuning parameter mtry was identified by a grid search.
In contrast to the tree-based model, Support Vector
Machine (SVM) is based on a statistical learning theory
derived from the structural risk minimization principle
and Vapnik-Chervonenkis (VC) dimension [31]. A soft
margin SVM with radial basis function (RBF) kernel in
the Gaussian form was used in the present study. The
optimal values for tuning parameters (C and λ) were de-
termined by a grid search using 10-fold cross-validation.
The classification performances were evaluated using




2TP þ FP þ FN ð1Þ
F1-score can be used for statistical hypothesis testing, in
particular, for imbalanced datasets. Both RF and SVM can
calculate the probabilities of classifications, and rankings can
be derived from the probability calculations. The predictive
performance on rankings was evaluated according to Re-
ceiver Operating Characteristic (ROC) and Precision Recall
(PR) curves for all of the models. The area under the curve
for ROC (AUCROC) and PR (AUCPR) were calculated
using the natural spline interpolation encoded in the R pack-
age ‘Miscellaneous Esoteric Statistical Scripts’ (MESS). The
early hit recognitions that are considered more important in
Table 3 Statistics of binary classification models built upon different
feature sets and using different machine learning algorithms
topological feature Dataset Random Forest Support Vector Machine
mtry F1-score C λ F1-score
Feature set I Training 12 0.780 8 0.250 0.766
Test 0.735 0.719
Feature set II Training 13 0.844 16 0.062 0.810
Test 0.790 0.763
Feature set III Training 13 0.859 16 0.016 0.843
Test 0.810 0.798
Fig. 2 Receiver operating characteristic curves (a) and precision/recall curves (b) for the six models using two machine learning algorithms to
build binary classification models upon three topological feature spaces. RF means Random Forest, SVM means support vector machine, FI means
feature set I, FII means feature set II, and FIII means feature set III
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virtual screening experiments were evaluated using
Boltzmann-enhanced discrimination of ROC (BEDROC),
which was calculated using the R package ‘enrichvs.’
Results and discussion
The optimal tuning parameters and the statistical re-
sults for all the binary classification models are summa-
rized in Table 3. RF outperformed SVM across all three
feature sets. Both RF and SVM yielded consistent rank-
ings of the predictive performance for the different
feature sets: feature set III > feature set II > feature set
I. The similarity neighboring links improved the link
prediction performance on test set by 5.5 % in RF
models, and by around 4.4 % in SVM models. In
combination with RW normalization, the predictive
performance of RF models was improved by 2 %, and
the predictive performance of SVM models were
boosted by 3.5 %. The differences in predictive per-
formance were consistently demonstrated by ROC and
PR curves as well (see Fig. 2). The ROC space and PR
space agreed on the rankings of different feature sets,
in terms of predictive performance. We can see that
feature set III dominated both ROC space and PR
space for both RF and SVM models, and RF models
slightly outperformed SVM models. Since we have im-
balanced distributions for positive and negative labels,
PR curves can provide better visual representations
than ROC curves to identify the difference of predictive
performance. As shown in Fig. 2, the ROC curves were
closely clustered, and the PR curves for different
models were separated to a larger extent. The differ-
ences among AUCPRs were larger than the differences
among AUCROCs, as well (see Table 4). It is clear that
similarity neighboring links are important for link pre-
diction in the semantic network, and RW normalization
can boost predictive performance by enriching feature
space. It is noteworthy that all the machine learning
models performed fairly well on both training and test
sets without over-fitting. In addition, both feature set II
and feature set III produced AUCROCs greater than
0.92, which was produced by SLAP [15]. Hence, meta-
path-based topological features have been proven to be
valuable for link prediction in complex semantic networks
using machine learning models.
In order to further compare the proposed approached
with SLAP, we carried out link predictions using both
methods on a large set of unknown links of an evolving
semantic network. The labels of those unknown links
were derived from experimental evidence deposited in
PubChem BioAssay databases after the Chem2Bio2RDF
network was constructed. Hence, these positive labels
can be viewed as experimental validations when asses-
sing link prediction performance. The proposed frame-
work, using RF to build a binary classification model
upon feature set III, yielded much better BEDROC and
AUCROC than SLAP (Table 5). BEDROC is mainly used
to compare ranking systems in terms of early recogni-
tion [33]. Our approach yielded much better AUC of
BEDROC using a default coefficient parameter (α = 20.0)
(Table 5). The difference can be seen in Fig. 3 as well.
By applying the intrinsic feature ranking algorithm of
the RF on feature set II, we can tell which meta-paths
are important for link prediction. Feature importance
can be visualized as a dot plot (Fig. 4). Two measures
evaluated before and after permutations were used for
feature ranking: decrease of classification accuracy and
decrease of Gini index. Although two measures do not
always agree on which features are important, we still
can identify some significantly important meta-paths
according to two measures. The top four important
meta-paths were C1, C19, C16, and C39, and the net-
work nodes connected by these important meta-paths
Table 4 Area under ROC curve (AUCROC) and area under PR
curve (AUCPR) of random forest and support vector machine
classification models using different feature sets
topological
feature
Random Forest Support Vector Machine
AUCROC AUCPR AUCROC AUCPR
Feature set I 0.891 0.772 0.871 0.729
Feature set II 0.927 0.826 0.905 0.768
Feature set III 0.938 0.857 0.922 0.795
Table 5 Comparing the proposed framework (random forest
classification model applied on feature set III) with existing
algorithm SLAP using Area under ROC curve (AUCROC) and
area under PR curve (AUCPR)
AUCROC BEDROC
Feature set III 0.845 0.929
SLAP 0.670 0.672
Fig. 3 ROC curves for the Random Forest model built upon feature set
III and SLAP. RF means Random Forest and FIII means feature set III
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Fig. 4 Variable importance for Random Forest model built with feature set II. The color code for feature importance according to mean decrease
accuracy: red (>70), blue (>45 and <70), green (<45); the color code for feature importance according to mean decrease Gini index: red (>240),
blue (>240 and <100), green (<100)
Fig. 5 Box plot for the variable importance varying in 1 000 Random Forest models
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are compounds, proteins, and GO annotations. It is
noteworthy that the top three important meta-paths
only contain semantic links between compounds and
proteins, and the top two important meta-paths contain
similarity neighboring links. Therefore, semantic links
between compounds and proteins, including similarity
neighboring links and interaction links, played a major
role in predicting CPIs.
In contrast to SLAP, that pre-calculates feature im-
portance before making predictions, the proposed
framework can evaluate feature importance and build
predictive models at the same time. The importance of a
given topological feature may vary to some extent when
different sets of training data are considered, or when
new links are added into the network as a function of
time. We carried out an experiment to demonstrate that
feature importance may vary significantly when different
sets of data are used to build predictive models. We
constructed 1,000 RF models using randomly selected
training sets with feature set II. Each training set was
compiled by 100 positively labeled links from the
DrugBank set, and 100 negatively labeled links from the
PubChem BioAssay set with experimental bioactivity
value greater than 10 μM. The changes of feature
importance in different models can be seen in Fig. 5. It
is clearly that feature importance varied a lot in different
models. Feature C4 has the smallest standard deviation
(0.828) and feature C39 has the largest standard devi-
ation (5.537). It is noteworthy that all of the top four
importance features in the aforementioned models (C1,
C16, C19, and C39) have very large standard deviations.
Even though their importance varied a lot in different
models, their mean values were well above the average
of others; in particular, the mean values of C1 and C39
were much larger than those of other topological
features. The predictive performances of those 1,000 RF
models tested against a randomly selected set of 50
positive labels and 50 negative labels (not included in
any of those 1,000 training sets) varied a lot as well. The
highest F1-score is 0.937 and the lowest F1-score is
0.667. Hence, the selection of training set is also
very important to build highly predictive machine
learning models.
Conclusions
The semantic network integrating domain knowledge
across chemical and biological space can be leveraged
for large-scale data mining. Among the different kinds
of semantic links, drug-target connectivity maps have
drawn extensive attention, since they are beneficial for
drug discovery and development, in particular, drug
repositioning and polypharmacology research. In the
present work, we have proposed a framework to con-
struct state-of-the-art machine learning models using
meta-path-based topological features for link prediction
in complex semantic networks. Supervised classification
models were shown to be powerful, based on their
predictive performance in an independent test set
containing links of an evolving network. In addition, the
intrinsic feature ranking algorithm embedded in ma-
chine learning models can be used to select the most
important topological features. Although the proposed
framework was only applied to predict DTIs in the
present work, it can definitely be used for other pur-
poses, such as to predict associations between drugs and
adverse side effects, as well as associations between
proteins and diseases. In the future, we want to study
how to select the most relevant training set for a given
prediction task, and how much training set selection can
improve predictive performance.
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semantic links of the augmented Chem2Bio2RDF graph and the labels
for internal test set, which has been blinded out from training set.
(ZIP 26931 kb)
Additional file 4: (metapath_commuting_matrix.zip): it contains the
calculated commuting matrix for internal and external validating. The
internal test set was used by SLAP in the original publication; the external
test set was prepared in the present study and intended to examine the
ability to predict evolving network topologies. (ZIP 27340 kb)
Additional file 5: (evolving_network_prediction.zip): it contains the
predicted results using SLAP and presented meta-path-based semantic
network analysis framework. (ZIP 4712 kb)
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